MAPT and Alzheimer disease: Mechanistically, Wnt signaling improves AD pathogenesis by suppressing tau phosphorylation via GSK3β [17], impairing Aβ aggregation via downregulation of β-site APP cleaving enzyme (BACE1) [18], enhancing synaptic plasticity [4], and promoting neurogenesis [19].